Cargando…

Description of a New Predictive Modeling Approach That Correlates the Risk and Associated Cost of Well-Defined Diabetes-Related Complications With Changes in Glycated Hemoglobin (HbA1c)

The modeling approach described here is designed to support the development of spreadsheet-based simple predictive models. It is based on 3 pillars: association of the complications with HbA1c changes, incidence of the complications, and average cost per event of the complication. For each pillar, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Fortwaengler, Kurt, Parkin, Christopher G., Neeser, Kurt, Neumann, Monika, Mast, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478016/
https://www.ncbi.nlm.nih.gov/pubmed/27510441
http://dx.doi.org/10.1177/1932296816662048
_version_ 1783244881793122304
author Fortwaengler, Kurt
Parkin, Christopher G.
Neeser, Kurt
Neumann, Monika
Mast, Oliver
author_facet Fortwaengler, Kurt
Parkin, Christopher G.
Neeser, Kurt
Neumann, Monika
Mast, Oliver
author_sort Fortwaengler, Kurt
collection PubMed
description The modeling approach described here is designed to support the development of spreadsheet-based simple predictive models. It is based on 3 pillars: association of the complications with HbA1c changes, incidence of the complications, and average cost per event of the complication. For each pillar, the goal of the analysis was (1) to find results for a large diversity of populations with a focus on countries/regions, diabetes type, age, diabetes duration, baseline HbA1c value, and gender; (2) to assess the range of incidences and associations previously reported. Unlike simple predictive models, which mostly are based on only 1 source of information for each of the pillars, we conducted a comprehensive, systematic literature review. Each source found was thoroughly reviewed and only sources meeting quality expectations were considered. The approach allows avoidance of unintended use of extreme data. The user can utilize (1) one of the found sources, (2) the found range as validation for the found figures, or (3) the average of all found publications for an expedited estimate. The modeling approach is intended for use in average insulin-treated diabetes populations in which the baseline HbA1c values are within an average range (6.5% to 11.5%); it is not intended for use in individuals or unique diabetes populations (eg, gestational diabetes). Because the modeling approach only considers diabetes-related complications that are positively associated with HbA1c decreases, the costs of negatively associated complications (eg, severe hypoglycemic events) must be calculated separately.
format Online
Article
Text
id pubmed-5478016
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-54780162018-03-01 Description of a New Predictive Modeling Approach That Correlates the Risk and Associated Cost of Well-Defined Diabetes-Related Complications With Changes in Glycated Hemoglobin (HbA1c) Fortwaengler, Kurt Parkin, Christopher G. Neeser, Kurt Neumann, Monika Mast, Oliver J Diabetes Sci Technol Review Articles The modeling approach described here is designed to support the development of spreadsheet-based simple predictive models. It is based on 3 pillars: association of the complications with HbA1c changes, incidence of the complications, and average cost per event of the complication. For each pillar, the goal of the analysis was (1) to find results for a large diversity of populations with a focus on countries/regions, diabetes type, age, diabetes duration, baseline HbA1c value, and gender; (2) to assess the range of incidences and associations previously reported. Unlike simple predictive models, which mostly are based on only 1 source of information for each of the pillars, we conducted a comprehensive, systematic literature review. Each source found was thoroughly reviewed and only sources meeting quality expectations were considered. The approach allows avoidance of unintended use of extreme data. The user can utilize (1) one of the found sources, (2) the found range as validation for the found figures, or (3) the average of all found publications for an expedited estimate. The modeling approach is intended for use in average insulin-treated diabetes populations in which the baseline HbA1c values are within an average range (6.5% to 11.5%); it is not intended for use in individuals or unique diabetes populations (eg, gestational diabetes). Because the modeling approach only considers diabetes-related complications that are positively associated with HbA1c decreases, the costs of negatively associated complications (eg, severe hypoglycemic events) must be calculated separately. SAGE Publications 2017-03-01 /pmc/articles/PMC5478016/ /pubmed/27510441 http://dx.doi.org/10.1177/1932296816662048 Text en © 2016 Diabetes Technology Society http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution 3.0 License (http://www.creativecommons.org/licenses/by/3.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Review Articles
Fortwaengler, Kurt
Parkin, Christopher G.
Neeser, Kurt
Neumann, Monika
Mast, Oliver
Description of a New Predictive Modeling Approach That Correlates the Risk and Associated Cost of Well-Defined Diabetes-Related Complications With Changes in Glycated Hemoglobin (HbA1c)
title Description of a New Predictive Modeling Approach That Correlates the Risk and Associated Cost of Well-Defined Diabetes-Related Complications With Changes in Glycated Hemoglobin (HbA1c)
title_full Description of a New Predictive Modeling Approach That Correlates the Risk and Associated Cost of Well-Defined Diabetes-Related Complications With Changes in Glycated Hemoglobin (HbA1c)
title_fullStr Description of a New Predictive Modeling Approach That Correlates the Risk and Associated Cost of Well-Defined Diabetes-Related Complications With Changes in Glycated Hemoglobin (HbA1c)
title_full_unstemmed Description of a New Predictive Modeling Approach That Correlates the Risk and Associated Cost of Well-Defined Diabetes-Related Complications With Changes in Glycated Hemoglobin (HbA1c)
title_short Description of a New Predictive Modeling Approach That Correlates the Risk and Associated Cost of Well-Defined Diabetes-Related Complications With Changes in Glycated Hemoglobin (HbA1c)
title_sort description of a new predictive modeling approach that correlates the risk and associated cost of well-defined diabetes-related complications with changes in glycated hemoglobin (hba1c)
topic Review Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478016/
https://www.ncbi.nlm.nih.gov/pubmed/27510441
http://dx.doi.org/10.1177/1932296816662048
work_keys_str_mv AT fortwaenglerkurt descriptionofanewpredictivemodelingapproachthatcorrelatestheriskandassociatedcostofwelldefineddiabetesrelatedcomplicationswithchangesinglycatedhemoglobinhba1c
AT parkinchristopherg descriptionofanewpredictivemodelingapproachthatcorrelatestheriskandassociatedcostofwelldefineddiabetesrelatedcomplicationswithchangesinglycatedhemoglobinhba1c
AT neeserkurt descriptionofanewpredictivemodelingapproachthatcorrelatestheriskandassociatedcostofwelldefineddiabetesrelatedcomplicationswithchangesinglycatedhemoglobinhba1c
AT neumannmonika descriptionofanewpredictivemodelingapproachthatcorrelatestheriskandassociatedcostofwelldefineddiabetesrelatedcomplicationswithchangesinglycatedhemoglobinhba1c
AT mastoliver descriptionofanewpredictivemodelingapproachthatcorrelatestheriskandassociatedcostofwelldefineddiabetesrelatedcomplicationswithchangesinglycatedhemoglobinhba1c